Get notified of page updates
Prevention study enrolling women ages 25-55 with a BRCA1 mutation
Clinicaltrials.gov identifier:NCT04711109
Denosumab for Breast Cancer Risk Reduction in Women With an Inherited BRCA1 Mutation (The Breast Cancer Prevention Study)

Prevention study enrolling women ages 25-55 with a BRCA1 mutation
Clinicaltrials.gov identifier:NCT04711109
Glossary on
off
About the Study
NOTE: This study is no longer recruiting patients.
The BRCA-P Study is an international research study for women who are born with a mutation (change) in one of their genes. The main purpose is to find out if the study medication, denosumab, can decrease the risk of developing breast cancer compared to a (inactive substance) in women with a BRCA1 gene mutation.
This Study is Open To:
NOTE: This study is no longer recruiting patients.
This Study is NOT Open To:
NOTE: This study is no longer recruiting patients.